Quantcast
Channel: Life Science Investing News» NewLink Genetics
Browsing latest articles
Browse All 4 View Live

Tekmira Pharmaceuticals Surges as Ebola Reaches United States

On Tuesday, the US Center for Disease Control confirmed the first case of Ebola in the country. As a result, shares of pharmaceutical companies researching a cure for the disease rose.Continue reading...

View Article



Johnson & Johnson Makes Late Entrance to Ebola Vaccine Race

Some market participants are wondering if Johnson & Johnson has entered the Ebola vaccine race too late. Continue reading...

View Article

More Testing Coming for Leading Ebola Vaccines

The Associated Press reported that the World Health Organization (WHO) has said that the two most advanced Ebola vaccines seem safe and are set to be tested on healthy volunteers in West Africa....

View Article

Merck, NewLink Begin Phase III Trial of Ebola Vaccine

Merck & Co. Inc. (NYSE:MRK) and NewLink Genetics Corp. (NASDAQ:NLNK) announced that the third late-stage clinical trial of their Ebola vaccine candidate has started up in Sierra Leone. Continue...

View Article
Browsing latest articles
Browse All 4 View Live




Latest Images